American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...

Given its immediacy, it is understandable that much of the economic debate has focused on President Donald Trump’s highly unorthodox import tariff policy.

Regeneron highlighted that about 35% of weight loss from semaglutide alone was due to lean mass loss, which combo therapies ...

The overturning of the FDA’s lab-developed tests rule is just the tip of the iceberg. With the loss of Chevron deference, ...

For Poolbeg Pharma, the question is not simply whether it can fund its ambitions, but whether its pipeline can justify them.

As we just marked Memorial Day and honored the hundreds of thousands of young, brave Americans who lost their lives in defense of the United States, one can’t help but ...

Novo Nordisk was Europe's most valuable company, with a big lead on obesity drugs with its runaway hits Ozempic and Wegovy.

The size of India’s insulin market was an estimated Rs 4,404 crore in April this year, with Indian players making steady ...

All three major averages closed out May with sizable gains Friday, with the S&P 500 and Nasdaq Composite seeing their best ...

All three major averages closed out May with sizable gains Friday, with the S&P 500 and Nasdaq Composite seeing their best ...

The global weight-loss drug market is experiencing exceptional growth, projected to expand from around $144.6 billion in 2023 ...

If you are looking to get a weight loss drug but lack insurance coverage, telehealth websites such as Ro, Hers and Mochi Health sell GLP-1 drugs for lower prices than what you’d pay at a pharmacy, ...